CBSTQ · Cannabist Co Holdings Inc.
$0.00
+0.00 (+0.00%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 10, 2025
Substantial doubt about the company's ability to continue as a going concern.
“The above conditions, together with uncertainty as to our ability to generate sufficient cash flow from operations, asset divestitures or external financing to meet our financial obligations including, without limitation, making interest payments on our senior debt or otherwise complying with our indenture obligations, absent material divestitures, significant concessions or consents from our creditors, raise substantial doubt about our ability to continue as a going concern for a period of at least one year from the date of this report.”View the 10-Q filed Nov 10, 2025
Market Cap
$49,746
Shares
497.46M
Volume · Oct 6
7177
Avg daily vol (3M)
148.4K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.00
Open$0.00
Day$0.00–0.00
52W close$0.00–0.12
Avg vol 30d155K
Short int73K · 0.0% float · 1.0d
Short vol27%
Last earningsNov 10, 2025
DataJan 2020–Oct 2026
Filing10-Q · Nov 10
Up next
filed Nov 10, 2025
call held Nov 10, 2025
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$349.84M
Trailing 12 months
Net income (TTM)
−$179.38M
Trailing 12 months
Revenue growth YoY
-30.4%
Year over year
Operating margin
-14.3%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-75,329.4%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$278.35M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+6.1%
Year over year · more shares
Price change (1Y)
-99.9%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−100%
below
Price vs 50-day avg
−67%
below
RSI (14)
42
neutral
MACD trend
Positive
52-week position
0%
near low
Momentum
relative strength
1-month return
0%
trailing
6-month return
−100%
trailing
YTD return
−100%
this year
Relative strength
−111%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.01% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
31
low risk · 0–100
Fundamentals
Revenue growth
−10%
Y/Y
Gross margin
37%
expanding
EPS growth
+48%
Y/Y
Free cash flow
$-29.2M
Quant / Vol
risk profile
Volatility
8930%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
400.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guided vs delivered
· last 1 settled
Revenue
2022 Guidance
guided $625M – $675M
$511.58M
Miss −21.3%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−100%
Bearish
Price vs 50-day avg
−67%
Bearish
RSI (14)
42
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.01% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $0
vs 200-day avg -100%
vs 50-day avg -67%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CBSTQ
this stock
Cannabist Co Holdings Inc.
|
$49,746 | -99.8% | -10.3% | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$62.65B | +28.8% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$48.88B | +2.4% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$48.14B | +30.9% | +4.3% | 67.7 | 2.6% |
|
HLN
Haleon plc
|
$44.72B | +0.6% | — | — | 0.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CBSTQ | +0.0% | +0.0% | -99.9% | +0.0% | -99.8% |
| SPY | +2.0% | +1.7% | +11.3% | +2.2% | +14.3% |
| vs SPY | -2.0% | -1.7% | -111.2% | -2.2% | -114.1% |